These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 16115767)

  • 21. Structure-activity relationships for the linker in a series of pyridinyl-alkynes that are antagonists of the metabotropic glutamate receptor 5 (mGluR5).
    Bach P; Nilsson K; Svensson T; Bauer U; Hammerland LG; Peterson A; Wållberg A; Osterlund K; Karis D; Boije M; Wensbo D
    Bioorg Med Chem Lett; 2006 Sep; 16(18):4788-91. PubMed ID: 16837196
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antagonists at metabotropic glutamate receptor subtype 5: structure activity relationships and therapeutic potential for addiction.
    Carroll FI
    Ann N Y Acad Sci; 2008 Oct; 1141():221-32. PubMed ID: 18991960
    [TBL] [Abstract][Full Text] [Related]  

  • 23. SAR study of a subtype selective allosteric potentiator of metabotropic glutamate 2 receptor, N-(4-phenoxyphenyl)-N-(3-pyridinylmethyl)ethanesulfonamide.
    Barda DA; Wang ZQ; Britton TC; Henry SS; Jagdmann GE; Coleman DS; Johnson MP; Andis SL; Schoepp DD
    Bioorg Med Chem Lett; 2004 Jun; 14(12):3099-102. PubMed ID: 15149652
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Non-competitive inhibitors of metabotropic glutamate receptor 5 (mGluR5).
    Tasler S; Kraus J; Pegoraro S; Aschenbrenner A; Poggesi E; Testa R; Motta G; Leonardi A
    Bioorg Med Chem Lett; 2005 Jun; 15(11):2876-80. PubMed ID: 15878659
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rational design of 7-arylquinolines as non-competitive metabotropic glutamate receptor subtype 5 antagonists.
    Milbank JB; Knauer CS; Augelli-Szafran CE; Sakkab-Tan AT; Lin KK; Yamagata K; Hoffman JK; Zhuang N; Thomas J; Galatsis P; Wendt JA; Mickelson JW; Schwarz RD; Kinsora JJ; Lotarski SM; Stakich K; Gillespie KK; Lam WW; Mutlib AE
    Bioorg Med Chem Lett; 2007 Aug; 17(16):4415-8. PubMed ID: 17590335
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis and SAR comparison of regioisomeric aryl naphthyridines as potent mGlu5 receptor antagonists.
    Galatsis P; Yamagata K; Wendt JA; Connolly CJ; Mickelson JW; Milbank JB; Bove SE; Knauer CS; Brooker RM; Augelli-Szafran CE; Schwarz RD; Kinsora JJ; Kilgore KS
    Bioorg Med Chem Lett; 2007 Dec; 17(23):6525-8. PubMed ID: 17936624
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro and in vivo SAR of pyrido[3,4-d]pyramid-4-ylamine based mGluR1 antagonists.
    Mantell SJ; Gibson KR; Osborne SA; Maw GN; Rees H; Dodd PG; Greener B; Harbottle GW; Million WA; Poinsard C; England S; Carnell P; Betts AM; Monhemius R; Prime RL
    Bioorg Med Chem Lett; 2009 Apr; 19(8):2190-4. PubMed ID: 19289283
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 6-Aryl-3-pyrrolidinylpyridines as mGlu5 receptor negative allosteric modulators.
    Weiss JM; Jimenez HN; Li G; April M; Uberti MA; Bacolod MD; Brodbeck RM; Doller D
    Bioorg Med Chem Lett; 2011 Aug; 21(16):4891-9. PubMed ID: 21757343
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Design, synthesis, and structure-activity relationships of novel bicyclic azole-amines as negative allosteric modulators of metabotropic glutamate receptor 5.
    Burdi DF; Hunt R; Fan L; Hu T; Wang J; Guo Z; Huang Z; Wu C; Hardy L; Detheux M; Orsini MA; Quinton MS; Lew R; Spear K
    J Med Chem; 2010 Oct; 53(19):7107-18. PubMed ID: 20809633
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recent advances in non-competitive mGlu5 receptor antagonists and their potential therapeutic applications.
    Slassi A; Isaac M; Edwards L; Minidis A; Wensbo D; Mattsson J; Nilsson K; Raboisson P; McLeod D; Stormann TM; Hammerland LG; Johnson E
    Curr Top Med Chem; 2005; 5(9):897-911. PubMed ID: 16178734
    [TBL] [Abstract][Full Text] [Related]  

  • 31. From pyrroles to 1-oxo-2,3,4,9-tetrahydro-1H-beta-carbolines: a new class of orally bioavailable mGluR1 antagonists.
    Di Fabio R; Micheli F; Alvaro G; Cavanni P; Donati D; Gagliardi T; Fontana G; Giovannini R; Maffeis M; Mingardi A; Tranquillini ME; Vitulli G
    Bioorg Med Chem Lett; 2007 Apr; 17(8):2254-9. PubMed ID: 17276684
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Unique antipsychotic activities of the selective metabotropic glutamate receptor 1 allosteric antagonist 2-cyclopropyl-5-[1-(2-fluoro-3-pyridinyl)-5-methyl-1H-1,2,3-triazol-4-yl]-2,3-dihydro-1H-isoindol-1-one.
    Satow A; Suzuki G; Maehara S; Hikichi H; Murai T; Murai T; Kawagoe-Takaki H; Hata M; Ito S; Ozaki S; Kawamoto H; Ohta H
    J Pharmacol Exp Ther; 2009 Jul; 330(1):179-90. PubMed ID: 19359526
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Scaffold hopping from pyridones to imidazo[1,2-a]pyridines. New positive allosteric modulators of metabotropic glutamate 2 receptor.
    Tresadern G; Cid JM; Macdonald GJ; Vega JA; de Lucas AI; García A; Matesanz E; Linares ML; Oehlrich D; Lavreysen H; Biesmans I; Trabanco AA
    Bioorg Med Chem Lett; 2010 Jan; 20(1):175-9. PubMed ID: 19932615
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A new series of pyridinyl-alkynes as antagonists of the metabotropic glutamate receptor 5 (mGluR5).
    Bach P; Nilsson K; Wållberg A; Bauer U; Hammerland LG; Peterson A; Svensson T; Osterlund K; Karis D; Boije M; Wensbo D
    Bioorg Med Chem Lett; 2006 Sep; 16(18):4792-5. PubMed ID: 16839764
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 3-Phenyl-5-isothiazole carboxamides with potent mGluR1 antagonist activity.
    Fisher MJ; Backer RT; Barth VN; Garbison KE; Gruber JM; Heinz BA; Iyengar S; Hollinshead SP; Kingston A; Kuklish SL; Li L; Nisenbaum ES; Peters SC; Phebus L; Simmons RM; van der Aar E
    Bioorg Med Chem Lett; 2012 Apr; 22(7):2514-7. PubMed ID: 22386665
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Group I mGluR5 metabotropic glutamate receptors regulate proliferation of neuronal progenitors in specific forebrain developmental domains.
    Gandhi R; Luk KC; Rymar VV; Sadikot AF
    J Neurochem; 2008 Jan; 104(1):155-72. PubMed ID: 17944877
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Discovery of novel modulators of metabotropic glutamate receptor subtype-5.
    Wang B; Vernier JM; Rao S; Chung J; Anderson JJ; Brodkin JD; Jiang X; Gardner MF; Yang X; Munoz B
    Bioorg Med Chem; 2004 Jan; 12(1):17-21. PubMed ID: 14697765
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel heterocyclic compounds as mGlu5 antagonists: WO2009015897.
    Doller D; Li G; Brodbeck RM; Thomsen C
    Expert Opin Ther Pat; 2010 Mar; 20(3):435-9. PubMed ID: 20180623
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metabotropic glutamate receptor antagonists: novel therapeutics for nicotine dependence and depression?
    Markou A
    Biol Psychiatry; 2007 Jan; 61(1):17-22. PubMed ID: 16876138
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Discovery and biological evaluation of tetrahydrothieno[2,3-c]pyridine derivatives as selective metabotropic glutamate receptor 1 antagonists for the potential treatment of neuropathic pain.
    Nam M; Kim T; Kwak J; Seo SH; Ko MK; Lim EJ; Min SJ; Cho YS; Keum G; Baek DJ; Lee J; Pae AN
    Eur J Med Chem; 2015 Jun; 97():245-58. PubMed ID: 25984841
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.